期刊文献+

环氧合酶-2在胃癌细胞中的表达及意义 被引量:3

Significance of cyclooxygenase-2 expression in human gastric carcinoma
暂未订购
导出
摘要 目的 通过研究环氧合酶 2 (COX 2 )在胃癌、癌前病变及慢性炎症中的表达情况 ,探讨COX 2与胃癌发生、发展的关系及意义。方法 采用免疫组化和原位分子杂交法 ,对 15例正常胃黏膜组织及 12 3例不同病变胃黏膜组织标本中COX 2进行检测。结果 COX 2蛋白在胃癌组织中的表达明显增强 ,其阳性率 (6 2 .2 6 % )显著高于正常胃黏膜、慢性浅表性胃炎、慢性萎缩性胃炎伴肠化及不典型增生胃黏膜组织 (6 .6 7% ,17.86 % ,30 .4 3% ,4 2 .11% ;P均 <0 .0 5 ) ;COX 2蛋白的阳性表达与胃癌组织学分级、浸润深度及有无淋巴结转移有关 ;高、中分化胃癌组中COX 2的表达明显高于低分化组 ;同时 ,在COX 2蛋白阳性的相关胃黏膜组织细胞中亦可见到COX 2mRNA的阳性表达。结论 COX 2的过度表达可能参与了胃癌形成的全过程 ,不仅在胃癌形成的早期 ,且与胃癌的侵袭、转移及预后亦有一定关系。 Objective To investigate the expression of cyclooxygenase-2(COX-2) in human gastric carcinoma,precarcinoma changes,chronic inflammation and to identify the significance of COX-2 expression.Methods COX-2 protein and mRNA were detected in 15 normal gastric mucosa(NGM),123 various gastric changes tissue specimens by using immunohistochemistry and in situ hybridization.Results There was a significantly much higher positive rate( 62.26% ) of cox-2 protein in gastric carcinoma(GC) than that in NGM,chronic superficial gastritis(CSG),chronic atrophic gastritis with intestinal metaplasia(CAG+IM) and atypical hyperplasia(Dys) tissues( 6.67% , 17.86% , 30.43% , 42.11% ;P< 0.05 respectively); The overexpression of COX-2 in GC was correlated with histological grade,invasive depth and lymph node metastasis.The higher the differentiation of gastric carcinoma,the more the expression of COX-2.At the same time,the expression of COX-2 mRNA was mostly observed in the related cells of gastric tissues with positive COX-2 protein.Conclusion The overexpression of COX-2 might participate in the whole process of the occurrence and development of gastric carcinoma,and relate to early dignosis or poor prognosis.
出处 《临床荟萃》 CAS 北大核心 2004年第14期784-786,共3页 Clinical Focus
关键词 胃癌 环氧合酶-2 免疫组织化学 原位分子杂交 gastric carcinoma cyclooxygenase-2 immunohistochemistry in situ hybridization
  • 相关文献

参考文献9

  • 1[1]WILLAMS C S, DDBOIS R N. Prostaglandin endoperoxide synthase: why two isoforms? [J]. Am J Physiol, 1996, 270(3ptl): G393-400.
  • 2[2]FOSSLIEN E. Molecular pathology of cyclooxygenase-2 in neoplasia[J]. Ann Clin Lab Sci,2000,30(1) :3-21.
  • 3[3]KUNE G A,KUNE S,WASTSON L F. Colorectal cancer risk,chronic illness, operations, and medications: case control from the Melbourne colorectal cancer study[J]. Cancer Res, 1988,48(1) :4399-4404.
  • 4[4]RISTIMAKI A, HONRANE N, JANKALA H, et al.Expression of cyclooxygenase-2 in human gastric carcinoma[J].Cancer Res,1997,57(57): 1276-1280.
  • 5[5]CORREA P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Socioty award Lecture on Cancer Epidemiology and Prevention [J]. Cancer Res,1992,52(24) :6735-6740.
  • 6[6]KONDO M, YAMAMOTO H, NAGNAO H, et al. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatic cellular carcinoma[J]. Clin Can Res, 1999,5 (12): 4005-4012.
  • 7[7]MURATA H,KAWANO S,TSUJI S, et al. Cyclooxygenase-2overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma[J]. Am J Gastroenterol, 1999,94(2):451-455.
  • 8[8]MCCARTHY C J, CROFFORD L J, GREENSON J, et al.Expression of cyclooxygenase-2 in gastric antral mucosa before and after eradicaton of Helicobacter pylori infection[J]. Am J Gastraenterol, 1999,94 (5) :1228-1223.
  • 9[9]FU S, RAMANUJAM K S, WONG A, et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase-2 in Helicobacter pylori gastritis[J]. Gastroenterol, 1999,116(6): 1319-1329.

同被引文献29

  • 1宋国华,徐宛玲.阿托伐他汀和辛伐他汀对急性冠状动脉综合征患者C反应蛋白和血脂的影响[J].临床荟萃,2005,20(20):1177-1178. 被引量:2
  • 2张洋,李建生,张金平.普伐他汀对人结肠癌细胞增殖及COX-2蛋白表达的影响[J].胃肠病学和肝病学杂志,2006,15(2):178-180. 被引量:5
  • 3中国慢性胃炎共识意见[J].胃肠病学,2006,11(11):674-684. 被引量:836
  • 4Jemal A,Siegel R,Ward E,et al. Cancer statistics,2008[J]. CA Cancer J Clin,2008,58(2) :71-96.
  • 5Sung JY, Lau JY, Goh KL, et al. Increasing incidence of colorectal cancer in Asia: Implications for screening. For the Asia Pacific Working Group on Colorectal Cancer[J]. Lancet Oncology,2005,6(11) :871-876.
  • 6Bresalier RS, Sandier RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J]. N Engl J Med,2005,352(11) :1092- 1020.
  • 7Poynter JN,Gruber SB,Higgins PD,et al. Statins and the risk of colorectal cancer[J]. N Engl J Med, 2005,352 (21) : 2184-2192.
  • 8Cipollone F, Fazia M, Iezzi A, et al. Suppression of the functionally coupled cyclooxygenase-2 / prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans[J]. Circulation, 2003,107 (11): 1479- 1485.
  • 9Habib A, Shamseddeen I, Nasrallah MS, et al. Modulation of COX-2 expression by statins in human monocytic cells[J]. FASEB J, 2007,21 (8) : 1665-1674.
  • 10Konturek PC, Burnat G, Hahn EG. Inhibition of Barret's adenocareinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins[J]-. J Physiol Pharmacol, 2007,58( Suppl 3):141-148.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部